Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the Covid-19 Vaccines

NCT04798677 is registered in ClinicalTrials.gov with AB Biotek as lead sponsor.

NCT NCT04798677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the Covid-19 Vaccines
Lead sponsor
AB Biotek
Phase
Not applicable
Overall status
Completed
Start date
October 29, 2020
Completion date
September 24, 2021
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, cytokine storm, immunity, immunologic deficiency syndromes, influenza, vaccine reaction